Cross-Neutralisation of Novel Bombali Virus by Ebola Virus Antibodies and Convalescent Plasma Using an Optimised Pseudotype-Based Neutralisation Assay. (2021)
Attributed to:
One Health and accelerating Vaccines for Ebola and Lassa (OVEL)
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.76064
Publication URI: https://www.repository.cam.ac.uk/handle/1810/328615
Type: Other